Full Text View
Tabular View
No Study Results Posted
Related Studies
Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients
This study has been completed.
Study NCT00333021   Information provided by GlaxoSmithKline

First Received on June 1, 2006.   Last Updated on July 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Venous Thromboembolism
Additional conditions recognized in this trial
Thromboembolism
Venous Thrombosis
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Thrombosis
Vascular Diseases
Interventions listed in this trial
Fondaparinux sodium
GSK576428
Additional drug interventions recognized in this trial
Fondaparinux
PENTA
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services